Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
January 27, 2023
Healthcare
-
-
Alkaline88® Adds Two Products in Sprouts Farmers Market
January 26, 2023
-
Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions
January 26, 2023
-
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
January 26, 2023
-
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
January 24, 2023
-
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
January 24, 2023
-
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
January 23, 2023
-
Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member
January 19, 2023
-
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
January 13, 2023
-
AXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
January 11, 2023
-
Augmedix Exits Calendar 2022 with Expected $35 Million in Annual Recurring Revenue
January 9, 2023
-
Newly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
January 3, 2023
-
AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent
December 13, 2022
-
22nd Century Group (XXII) Comments on the Advancement of New Zealand’s National Reduced Nicotine Content Law
December 13, 2022
-
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
December 12, 2022
-
Alkaline88® Strengthens Its Position in Gold’s Gyms
December 7, 2022